Candriam Equities L Oncology Impact I
LU1864482515
Candriam Equities L Oncology Impact I/ LU1864482515 /
NAV 04.06.2024
Diff.+8,8101
Ertragstyp
Ausrichtung
Fondsgesellschaft
2.201,1001 GBP
+0,40%
thesaurierend
Aktien
weltweit
Candriam ▶
Kennzahlen und Performance in:
Alle Kurse in GBP
Tranchen
Titel
Ertragstyp
Rückn. Preis
1 Jahr
3 Jahre
Candriam Equities L Oncology Imp...
thesaurierend
2.367,2800
+6,52%
+4,60%
Candriam Equities L Oncology Imp...
thesaurierend
2.529,7300
+6,66%
+4,99%
Candriam Equities L Oncology Imp...
thesaurierend
204,7500
+3,02%
-6,21%
Candriam Equities L Oncology Imp...
thesaurierend
2.201,1001
+3,10%
+14,90%
Candriam Equities L Oncology Imp...
ausschüttend
1.588,4700
+6,18%
+3,59%
Candriam Equities L Oncology Imp...
thesaurierend
241,6300
+3,56%
+12,59%
Candriam Equities L Oncology Imp...
ausschüttend
232,8300
+5,19%
+0,73%
Candriam Equities L Oncology Imp...
ausschüttend
188,6100
+6,09%
+3,30%
Candriam Equities L Oncology Imp...
ausschüttend
20.379,0000
+1,22%
+0,36%
Candriam Equities L Oncology Imp...
thesaurierend
155,7100
+2,98%
+14,51%
Candriam Equities L Oncology Imp...
thesaurierend
2.082,6499
+4,00%
-3,52%
Candriam Equities L Oncology Imp...
thesaurierend
256,1200
+4,44%
+15,47%
Candriam Equities L Oncology Imp...
thesaurierend
204,2100
+2,61%
-7,31%
Candriam Equities L Oncology Imp...
thesaurierend
282,8100
+6,08%
+3,28%
Candriam Equities L Oncology Imp...
thesaurierend
191,2800
+3,89%
-
Candriam Equities L Oncology Imp...
thesaurierend
1.815,7800
+3,43%
-
Candriam Equities L Oncology Imp...
thesaurierend
2.843,2800
+6,18%
+3,59%
Candriam Equities L Oncology Imp...
thesaurierend
155,3200
-
-
Candriam Equities L Oncology Imp...
thesaurierend
270,5100
+5,19%
+0,71%
Performance
lfd. Jahr
+6,88%
6 Monate
+10,66%
1 Jahr
+3,10%
3 Jahre
+14,90%
5 Jahre
-
10 Jahre
-
seit Beginn
+46,74%
Jahr
2023
-4,59%
2022
+1,72%
2021
+4,39%